[
  {
    "ts": null,
    "headline": "How Quest Diagnostics’ 25% Rally and AI Push Are Shaping Its 2025 Valuation",
    "summary": "If you are grappling with what to do next about Quest Diagnostics stock, you are certainly not alone. The company’s performance has been catching some attention lately and for good reason. Quest Diagnostics is fresh off a period of steady share price gains, with the stock up 2.9% over the last week and showing a healthy 5.1% rise over the past month. Step back a bit further, and the story looks even more impressive: a year-to-date gain of 25.2% and an 83.2% return over five years highlight...",
    "url": "https://finnhub.io/api/news?id=9c4ee1bc6ec7ffe415163ac4d43bbeb1cfe88b202cf93c7bb52286e7a4b2691c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758980597,
      "headline": "How Quest Diagnostics’ 25% Rally and AI Push Are Shaping Its 2025 Valuation",
      "id": 136904312,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "If you are grappling with what to do next about Quest Diagnostics stock, you are certainly not alone. The company’s performance has been catching some attention lately and for good reason. Quest Diagnostics is fresh off a period of steady share price gains, with the stock up 2.9% over the last week and showing a healthy 5.1% rise over the past month. Step back a bit further, and the story looks even more impressive: a year-to-date gain of 25.2% and an 83.2% return over five years highlight...",
      "url": "https://finnhub.io/api/news?id=9c4ee1bc6ec7ffe415163ac4d43bbeb1cfe88b202cf93c7bb52286e7a4b2691c"
    }
  }
]